NutriBand (NTRB) Short term Debt (2016 - 2020)

NutriBand (NTRB) posted Short term Debt of $67500.0 for Q1 2020, up 65.02% sequentially from $40905.0 in Q2 2018.

NutriBand (NTRB) Short term Debt (2016 - 2020) Analysis & Trends

NutriBand has reported Short term Debt for 4 years, with the latest figure at $67500.0 in Q1 2020.

Quarterly Short term Debt changed N/A year-over-year to $67500.0 in Q1 2020, while the trailing twelve-month figure through Jan 2020 was $67500.0 (changed N/A YoY) and the FY2020 annual result came in at $67500.0, changed N/A from the prior year.
Short term Debt rose to $67500.0 in Q1 2020 per NTRB's latest filing, from $40905.0 in the prior quarter.
Over five years, Short term Debt peaked at $67500.0 in Q1 2020 and troughed at $900.0 in Q1 2016.
A 4-year average of $16429.6 and a median of $9651.0 in 2017 frame the typical range for Short term Debt.
The sharpest annual moves came in 2017 and 2018: Short term Debt soared 980.0% in 2017, then jumped 60.1% in 2018.
Over 4 years, Short term Debt stood at $1153.0 in 2016, then soared by 731.05% to $9582.0 in 2017, then surged by 326.89% to $40905.0 in 2018, then soared by 65.02% to $67500.0 in 2020.
According to Business Quant data, Short term Debt over the past three periods registered $67500.0, $40905.0, and $14230.0 for Q1 2020, Q2 2018, and Q1 2018 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-
10	NutriBand	57.74 Mn	53.73 Mn	196,801.00

Download Data